Form 4: Nevro Corp. Executive Richard B. Carter Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Richard B. Carter, Chief Accounting Officer of Nevro Corp., reports acquisition and disposal of common stock and restricted stock units.
Summary
- On March 7, 2024, Richard B. Carter, Chief Accounting Officer of Nevro Corp., reported changes in beneficial ownership.
- Carter acquired 16,866 shares of common stock at $0.
- He also disposed of 2,706 shares of common stock at $15.32.
- Following these transactions, Carter beneficially owns 50,646 shares of common stock, which includes 41,495 RSUs.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document primarily reports transactions without expressing a clear positive or negative outlook. The acquisition and disposal could have various motivations.
Positives
- The acquisition of 16,866 shares at $0 suggests a grant or award of stock.
Negatives
- The disposal of 2,706 shares at $15.32 indicates a sale of stock by the reporting person.
Future Outlook
The vesting schedule of the RSUs extends to the third anniversary of the grant date, contingent on continued service.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.
Comparison to Industry Standards
- Monitoring insider transactions is a common practice in financial analysis.
- Comparing the volume and frequency of insider buying and selling activity at Nevro Corp. to its peers in the medical device industry can provide insights into relative valuation and growth expectations.
- Companies like Medtronic, Boston Scientific, and Abbott Laboratories are often used as benchmarks for assessing the performance and insider activity of medical device companies.
Stakeholder Impact
- Shareholders may interpret insider transactions as a signal of management's confidence or lack thereof in the company's future performance.
- Employees holding company stock or options may be interested in the vesting schedule and potential value of their holdings.
Key Dates
| Date | Description |
|---|---|
| 03/07/2024 | Date of the reported transactions (acquisition and disposal of shares). |
| 03/07/2025 | Date when 1/3rd of the RSUs will vest. |
| 03/11/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.